| |
|
|
|
Summit Therapeu ADR  
|
|
4.5 0.16 (0.04%) |
11-30 16:00 |
|
Open: |
4.38 |
Pre close: |
4.34 |
Target:
|
6.42 
|
|
High: |
4.55 |
Low: |
4.38 |
Resistance:
|
5.50
6.42
|
|
Volume: |
115,881 |
Market Cap: |
370M |
Support:
|
4.09
3.22
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
4.35
|
MACD |
MACD(12,26):
|
0.26 |
|
MA(20): |
4.03 |
Signal(12,26,9): |
0.25 |
|
MA(100): |
3.58 |
Stochastic Oscillator |
%K(14,3):
|
50.58 |
|
MA(250): |
2.92 |
%D(3): |
48.05 |
|
Average Volume(K) |
3-Month: |
11117
|
52-Week |
High:
|
5.50 |
|
10-Days: |
23196 |
Low: |
1.18 |
|
RSI |
RSI(14):
|
65.23 |
Change(%): |
206.1 |
|
Financials, Statistics and Valuation |
|
EPS |
0.000 |
Return on Equity (ttm) |
0.0 |
Shares Out. (M) |
0.00 |
|
EPS Est. Current Year |
-0.530 |
Return on Assets (ttm) |
0.0 |
Shares Float (M) |
0.00 |
|
EPS Est. Next Year |
-1.050 |
PEG Ratio |
0.00 |
% Held by Insiders |
0.00 |
|
EPS Est. Next Quarter |
-0.620 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
0.00 |
|
Forward EPS |
0.118 |
Gross Profit (p.s.) |
0.256 |
Shares Short (K) |
0 |
|
Book Value (p.s.) |
0.000 |
EBITDA (p.s.) |
-0.619 |
P/E |
0.00 |
|
Sales Per Share |
0.314 |
Qtrly Earnings Growth |
0.00 |
P/BV |
0.00 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
0.00 |
P/S |
14.32 |
|
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
0.00 |
P/CF |
0.00 |
|
|
|
|
|
|
